Endymed Ltd (ENDY.TA)
ILA 282.7
(-2.75%)
ILA 282.7
(-2.75%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.21 Million USD | 4.47% |
| 2022 | 4.99 Million USD | -14.46% |
| 2021 | 5.83 Million USD | 14.9% |
| 2020 | 5.08 Million USD | -14.3% |
| 2019 | 5.92 Million USD | 10.82% |
| 2018 | 5.34 Million ILS | -28.98% |
| 2017 | 7.53 Million ILS | 81.19% |
| 2016 | 4.15 Million USD | 20.18% |
| 2015 | 3.45 Million USD | -9.95% |
| 2014 | 3.84 Million USD | 88.76% |
| 2013 | 2.03 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 4.9 Million USD | -9.09% |
| 2024 Q1 | 5.39 Million USD | 3.36% |
| 2023 Q1 | 5.13 Million USD | 2.8% |
| 2023 Q3 | 5.54 Million USD | -6.84% |
| 2023 Q2 | 5.95 Million USD | 15.92% |
| 2023 FY | 5.21 Million USD | 4.47% |
| 2023 Q4 | 5.21 Million USD | -5.9% |
| 2022 FY | 4.99 Million USD | -14.46% |
| 2022 Q2 | 5.02 Million USD | -12.16% |
| 2022 Q4 | 4.99 Million USD | -1.11% |
| 2022 Q3 | 5.04 Million USD | 0.42% |
| 2022 Q1 | 5.72 Million USD | -1.94% |
| 2021 FY | 5.83 Million USD | 14.9% |
| 2021 Q2 | 6.21 Million USD | 0.0% |
| 2021 Q4 | 5.83 Million USD | 0.0% |
| 2021 Q1 | - USD | -100.0% |
| 2020 Q4 | 5.08 Million USD | 0.0% |
| 2020 Q1 | 4.32 Million USD | -27.07% |
| 2020 FY | 5.08 Million USD | -14.3% |
| 2020 Q2 | 4.32 Million USD | 0.0% |
| 2020 Q3 | 5.08 Million USD | 17.51% |
| 2019 Q4 | 5.92 Million USD | 22.33% |
| 2019 FY | 5.92 Million USD | 10.82% |
| 2019 Q1 | 5.17 Million ILS | -3.22% |
| 2019 Q2 | 5.19 Million ILS | 0.35% |
| 2019 Q3 | 4.84 Million ILS | -6.72% |
| 2018 Q1 | 5.22 Million USD | -5.94% |
| 2018 Q3 | 3.9 Million USD | -26.5% |
| 2018 Q4 | 5.34 Million ILS | 36.91% |
| 2018 Q2 | 5.31 Million USD | 1.76% |
| 2018 FY | 5.34 Million ILS | -28.98% |
| 2017 Q3 | 5.18 Million USD | 17.57% |
| 2017 FY | 7.53 Million ILS | 81.19% |
| 2017 Q4 | 5.55 Million USD | 7.22% |
| 2017 Q2 | 4.4 Million USD | 3.74% |
| 2017 Q1 | 4.24 Million USD | 2.17% |
| 2016 Q4 | 4.15 Million USD | 16.51% |
| 2016 Q1 | 3.44 Million USD | -0.4% |
| 2016 FY | 4.15 Million USD | 20.18% |
| 2016 Q2 | 3.76 Million USD | 9.23% |
| 2016 Q3 | 3.56 Million USD | -5.18% |
| 2015 Q3 | 3.72 Million USD | 3.24% |
| 2015 FY | 3.45 Million USD | -9.95% |
| 2015 Q4 | 3.45 Million USD | -7.12% |
| 2015 Q1 | 3.88 Million USD | 1.17% |
| 2015 Q2 | 3.6 Million USD | -7.18% |
| 2014 Q3 | 3.07 Million USD | 25.68% |
| 2014 Q1 | 2.2 Million USD | 8.48% |
| 2014 Q2 | 2.45 Million USD | 11.01% |
| 2014 FY | 3.84 Million USD | 88.76% |
| 2014 Q4 | 3.84 Million USD | 24.71% |
| 2013 FY | 2.03 Million USD | 0.0% |
| 2013 Q2 | 1.69 Million USD | 15.74% |
| 2013 Q3 | 1.82 Million USD | 7.6% |
| 2013 Q4 | 2.03 Million USD | 11.46% |
| 2013 Q1 | 1.46 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|